Ventilator Tubing Correction: Percussionaire Corporation Updates Use Instructions for Phasitron In-Line Valve
Percussionaire Corporation has released updated instructions for use regarding ventilator tubes due to a design defect in the Phasitron In-Line Valve. The defect reportedly poses risks of hypoventilation and respiratory failure.
This affects Percussionaire Corporation, medical device distributors, and healthcare facilities utilizing Phasitron In-Line Valves and associated ventilator tubing.
The classification of the defect as a 'design defect' suggests that the issue may reside in the fundamental engineering of the valve rather than a transient manufacturing error. Regulatory professionals should note that updating instructions for use (IFU) is a common mitigation strategy, but it may precede further enforcement actions or formal recalls if the design defect cannot be remediated through labeling alone. The potential for respiratory failure indicates a significant clinical risk profile.
Quality and regulatory teams should immediately verify that user instructions for the Phasitron In-Line Valve are updated to the latest revision. Clinical departments using these ventilator tubes must be briefed on the design defect and the potential for hypoventilation to ensure appropriate patient monitoring.
Percussionaire Corporation issues updated instructions for ventilator tubes due to design defect that could cause hypoventilation, respiratory failure
Open in openFDA / FDA.gov